Cytokine gene polymorphisms as risk and severity factors for juvenile dermatomyositis.

OBJECTIVE To study tumor necrosis factor alpha (TNFalpha) and interleukin-1 (IL-1) cytokine polymorphisms as possible risk and protective factors, define their relative importance, and examine these as severity factors in patients with juvenile dermatomyositis (DM). METHODS TNFalpha and IL-1 cytokine polymorphism and HLA typing were performed in 221 Caucasian patients with juvenile DM, and the results were compared with those in 203 ethnically matched healthy volunteers. RESULTS The genotypes TNFalpha -308AG (odds ratio [OR] 3.6), TNFalpha -238GG (OR 3.5), and IL-1alpha +4845TT (OR 2.2) were risk factors, and TNFalpha -308GG (OR 0.26) as well as TNFalpha -238AG (OR 0.22) were protective, for the development of juvenile DM. Carriage of a single copy of the TNFalpha -308A (OR 3.8) or IL-1beta +3953T (OR 1.7) allele was a risk factor, and the TNFalpha -238A (OR 0.29) and IL-1alpha +4845G (OR 0.46) alleles were protective, for juvenile DM. Random Forests classification analysis showed HLA-DRB1*03 and TNFalpha -308A to have the highest relative importance as risk factors for juvenile DM compared with the other alleles (Gini scores 100% and 90.7%, respectively). TNFalpha -308AA (OR 7.3) was a risk factor, and carriage of the TNFalpha -308G (OR 0.14) and IL-1alpha -889T (OR 0.41) alleles was protective, for the development of calcinosis. TNFalpha -308AA (OR 7.0) was a possible risk factor, and carriage of the TNFalpha -308G allele (OR 0.14) was protective, for the development of ulcerations. None of the studied TNFalpha, IL-1alpha, and IL-1beta polymorphisms were associated with the disease course, disease severity at the time of diagnosis, or the patient's sex. CONCLUSION TNFalpha and IL-1 genetic polymorphisms contribute to the development of juvenile DM and may also be indicators of disease severity.

[1]  A. Xu,et al.  Tumor necrosis factor‐alpha‐308G/A promoter polymorphism is associated with the susceptibility of polymyositis/dermatomyositis in a Chinese Han population , 2007, The Journal of dermatology.

[2]  D. Glass,et al.  Non-HLA gene polymorphisms in juvenile rheumatoid arthritis. , 2003, Clinical and experimental rheumatology.

[3]  M. Carrington,et al.  Immunogenetic Risk and Protective Factors for the Idiopathic Inflammatory Myopathies: Distinct HLA-A, -B, -Cw, -DRB1, and -DQA1 Allelic Profiles Distinguish European American Patients With Different Myositis Autoantibodies , 2006, Medicine.

[4]  K. Sullivan,et al.  Associations of Tumor Necrosis Factor α and HLA Polymorphisms with Adult Dermatomyositis: Implications for a Unique Pathogenesi1 , 2002 .

[5]  S. Holm.  A Simple Sequentially Rejective Multiple Test Procedure , 1979 .

[6]  Jun Wang,et al.  EFFECTS OF HAPLOTYPES IN THE INTERLEUKIN 1&bgr; PROMOTER ON LIPOPOLYSACCHARIDE-INDUCED INTERLEUKIN 1&bgr; EXPRESSION , 2006, Shock.

[7]  L. Pachman,et al.  Expression of TNFα by muscle fibers in biopsies from children with untreated juvenile dermatomyositis : Association with the TNFα-308A allele , 2001 .

[8]  D. Kleiner,et al.  Late-onset gastrointestinal pain in juvenile dermatomyositis as a manifestation of ischemic ulceration from chronic endarteropathy. , 2007, Arthritis and rheumatism.

[9]  P. Miossec,et al.  IL-1B and IL-1Ra gene polymorphisms and disease severity in rheumatoid arthritis: interaction with their plasma levels , 2001, Genes and Immunity.

[10]  J. Barrett,et al.  Association of specific interleukin 1 gene cluster polymorphisms with increased susceptibility for Behcet's disease. , 2003, Rheumatology.

[11]  G. Ferraccioli,et al.  IL-1B and IL-1RN gene polymorphisms in rheumatoid arthritis: relationship with protein plasma levels and response to therapy. , 2006, Pharmacogenomics.

[12]  W. Crowe,et al.  Clinical and pathogenetic implications of histopathology in childhood polydermatomyositis. , 1982, Arthritis and rheumatism.

[13]  F. Breedveld,et al.  Correlation of polymorphic variation in the promoter region of the interleukin‐1β gene with secretion of interleukin‐1β protein , 2004 .

[14]  F. Miller,et al.  Mechanisms of Disease: environmental factors in the pathogenesis of rheumatic disease , 2007, Nature Clinical Practice Rheumatology.

[15]  R. Cooper,et al.  Tumour necrosis factor-α single nucleotide polymorphisms are not independent of HLA class I in UK Caucasians with adult onset idiopathic inflammatory myopathies , 2007 .

[16]  A. Bohan,et al.  Polymyositis and dermatomyositis (second of two parts). , 1975 .

[17]  N. Kamatani,et al.  Association of IL1A gene polymorphisms with susceptibility to and severity of systemic sclerosis in the Japanese population. , 2003, Arthritis and rheumatism.

[18]  A. Bohan,et al.  Polymyositis and dermatomyositis (second of two parts). , 1975, The New England journal of medicine.

[19]  F. Pociot,et al.  A Taql polymorphism in the human interleukin‐1β (IL‐1β) gene correlates with IL‐1β secretion in vitro , 1992 .

[20]  L. Pachman,et al.  TNFα-308A allele in juvenile dermatomyositis: Association with increased production of tumor necrosis factor α, disease duration, and pathologic calcifications , 2000 .

[21]  S. Jimenez,et al.  Polymorphisms in the IL‐1 receptor antagonist gene VNTR are possible risk factors for juvenile idiopathic inflammatory myopathies , 2000, Clinical and experimental immunology.

[22]  F. Breedveld,et al.  Relationship of polymorphisms of the Interleukin-1 gene cluster to occurrence and severity of rheumatoid arthritis. , 2002, Tissue antigens.

[23]  Wei Zhang,et al.  Association of a promoter polymorphism of tumor necrosis factor-alpha with subacute cutaneous lupus erythematosus and distinct photoregulation of transcription. , 2000, The Journal of investigative dermatology.

[24]  Shuying Sun,et al.  Association between the interleukin-1 family gene cluster and psoriatic arthritis. , 2006, Arthritis and rheumatism.

[25]  R. Płoski,et al.  A genetic association between juvenile rheumatoid arthritis and a novel interleukin-1α polymorphism , 1995 .

[26]  G. Cooper,et al.  Systemic lupus erythematosus and genetic variation in the interleukin 1 gene cluster: a population based study in the southeastern United States , 2003, Annals of the rheumatic diseases.

[27]  C. Lewis,et al.  A candidate gene analysis of three related photosensitivity disorders: cutaneous lupus erythematosus, polymorphic light eruption and actinic prurigo , 2001, The British journal of dermatology.

[28]  I. Lundberg.  The role of cytokines, chemokines, and adhesion molecules in the pathogenesis of idiopathic inflammatory myopathies , 2000, Current rheumatology reports.

[29]  J. Friedman,et al.  Immunogenetic studies of juvenile dermatomyositis: HLA-DR antigen frequencies. , 1983, Arthritis and rheumatism.

[30]  E. Hoffman,et al.  Journal of Autoimmune Diseases BioMed Central , 2006 .

[31]  Sharon Adams,et al.  Immunogenetic risk and protective factors for juvenile dermatomyositis in Caucasians. , 2006, Arthritis and rheumatism.

[32]  R. Siekmeier,et al.  Safety of in vitro Diagnostics for Hematology and Coagulation Testing – Analysis of the Reports to the German Competent Authority (BfArM) , 2007, Transfusion Medicine and Hemotherapy.

[33]  L. Padyukov,et al.  Association of the proinflammatory haplotype (MICA5.1/TNF2/TNFa2/DRB1*03) with polymyositis and dermatomyositis. , 2004, Arthritis and rheumatism.

[34]  G. Cooper,et al.  Genetic polymorphisms in tumor necrosis factor (TNF)-α and TNF-β in a population-based study of systemic lupus erythematosus: associations and interaction with the interleukin-1α-889 C/T polymorphism , 2004 .